Cell Death and Disease (Apr 2022)

SorCS3 promotes the internalization of p75NTR to inhibit GBM progression

  • Yanqiu Zhang,
  • Yue Li,
  • Yuhua Fan,
  • Xiaoyuan Zhang,
  • Zhihong Tang,
  • Jing Qi,
  • Baoshan Zhao,
  • Fuyuan Li,
  • Xiaofeng Chen,
  • Huan Liang,
  • Haiyan Xu,
  • Dongliang Li

DOI
https://doi.org/10.1038/s41419-022-04753-5
Journal volume & issue
Vol. 13, no. 4
pp. 1 – 12

Abstract

Read online

Abstract Glioblastoma (GBM) is a fatal malignancy caused by dysregulation of cellular signal transduction. Internalization plays a key role in maintaining signalling balance. Previous reports showed that Sortilin related VPS10 domain containing receptor 3 (SorCS3) has the ability to regulate internalization. However, the impacts of SorCS3 on the biological processes involved in GBM have not yet been reported. In this study, we investigated the bio-function of SorCS3 in GBM. We found that SorCS3 was significantly downregulated in GBM. In addition, low expression level of SorCS3 predicted poor prognoses in patients with GBM. Here, we proved that SorCS3 suppressed cell invasion and proliferation mainly via NGF/p75NTR pathway in GBM. We found that SorCS3 co-localized with p75NTR in GBM cells and regulated the p75NTR protein level by promoting trafficking of the endosomal to the lysosome. Immunofluorescence (IF) and Co-Immunoprecipitation (Co-IP) detection confirmed that SorCS3 bound to p75NTR, which subsequently increased the internalization of p75NTR, and then transported p75NTR to the lysosome for degradation, ultimately contributing to inhibit of glioma progression. Taken together, our work suggests that SorCS3 is a marker of promising prognosis in GBM patients and suggests that SorCS3 regulates internalization, which plays a pivotal role in inhibiting glioma progression.